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FIRST CLINICAL CASE REPORTLinezolid-resistant mucoid Staphylococcus haemolyticus from a
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gmail.com (V. Bhandari)IntroductionStaphylococcus haemolyticus is the second most frequently iso-
lated coagulase-negative Staphylococcus from bloodstream in-
fections and is often multidrug resistant [1]. We report an
unusual morphological mucoid variant of S. haemolyticus asso-
ciated with linezolid (LZ) resistance, from a patient with sepsis.
To our knowledge, this is the ﬁrst such report.Case ReportA 55-year-old man sought care at the emergency department
after a road trafﬁc accident. At examination he had multiple
tissue injuries with loss of consciousness. Ultrasound revealed
right lobe liver injury, and a computed tomographic scan
demonstrated subarachnoid hemorrhages with multiple con-
tusions. On the second day in the intensive care unit heNew Microbes and New Infections © 2016 The Authors. Published by El
This is an open access artideveloped high-grade fever. Total leukocyte count and eryth-
rocyte sedimentation rate indicated sepsis.
Blood culture showed growth of smooth, nonpigmented
mucoid colonies on blood and MacConkey agar which were
indistinguishable from colonies of Klebsiella spp. (Fig. 1). Gram
staining revealed Gram-positive cocci in clusters, which were
catalase positive and negative for tube coagulase, mannitol
fermentation and ornithine decarboxylase. The strain was
identiﬁed by Vitek MS (bioMérieux) as S. haemolyticus and
further conﬁrmed by ampliﬁcation of the 16S rRNA gene using
universal primers (forward: 50-AGAGTTTGATCMTGGCT-
CAG-30, reverse: 50-TACGYTACCTTGTTACGACTT-30) [2].
Antimicrobial susceptibility performed as per Clinical and
Laboratory Standards Institute guidelines [3] showed resistance
to penicillin, cefoxitin, gentamicin, erythromycin and clinda-
mycin. Minimum inhibitory concentration values for LZ (32 μg/
mL) and vancomycin (1 μg/mL) demonstrated the strain to be
vancomycin sensitive and LZ resistant. LZ resistance mediated
by cfr gene was detected by PCR using the forward (50-TGA
AGT ATA AAG CAG GTT 3GG AG-30) and reverse (50-ACC
ATA TA A TTG ACC ACA AGC AG-30) primers [4].
DiscussionMucoid variants of Staphylococcus aureus have been previously
been described [5,6]. However isolation of mucoidNew Microbe and New Infect 2016; 11: 57–58
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FIG. 1. Staphylococcus haemolyticus showing mucoid colonies.
58 New Microbes and New Infections, Volume 11 Number C, May 2016 NMNIS. haemolyticus has not yet been reported. The mucoid nature of
isolates has been attributed to the production of capsular
polysaccharides, which in turn lead to enhanced virulence [5].
S. haemolyticus has been shown to have capsular polysaccharide
by electron microscopy; however, production of visible mucoid
colonies on culture media has not previously been reported [1].
The mucoid colonies of S. haemolyticus were indistinguishable
from Klebsiella spp. and retained mucoid characteristic on serial
subcultures. The patient was treated with vancomycin, as the
isolate was susceptible. However, the patient died of infection,
which could be attributed to the higher virulence of the mucoid
strain and to other comorbidities in the patient. Although LZ
resistance mediated through the cfr gene has previously been
reported among methicillin-resistant, coagulase-negative
staphylococci after exposure to LZ, our isolate was mucoid and
resistant to LZ without a history of exposure [6,7].
Although extremely rare, microbiologists should be aware of
the existence of mucoid variants of S. haemolyticus from clinicalNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licespecimens and should carefully differentiate these species from
coliforms. Furthermore, infection control practices should be
stringently followed in hospitals, as strains carrying plasmid-
mediated resistance could act as reservoirs in the hospital
and spread horizontally among patients and within species.
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